Skip to main content Skip to section navigation Skip to footer
Back to eksoBIONICS.com
Ekso Bionics Holdings, Inc.
  • Investors
  • Overview
  • Press Releases
  • Presentations & Events
    • Overview
    • Presentations
    • IR Calendar
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Historical Data
    • Analyst Coverage
    • Form 8937
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Management Team
  • Investor Resources
    • Contacts
    • Email Alerts
    • RSS News Feed

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Presentations & Events
    • Overview
    • Presentations
    • IR Calendar
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Historical Data
    • Analyst Coverage
    • Form 8937
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Management Team
  • Investor Resources
    • Contacts
    • Email Alerts
    • RSS News Feed
Sep 11, 2023 8:00am EDT

Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference

Jul 27, 2023 4:05pm EDT

Ekso Bionics Reports Record Revenues of $4.7 Million in Second Quarter 2023

Jul 20, 2023 8:00am EDT

Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023

Apr 27, 2023 4:05pm EDT

Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues

Apr 20, 2023 8:00am EDT

Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023

Apr 17, 2023 4:05pm EDT

Ekso Bionics Announces Ekso Indego Therapy Order by SoldierStrong

Mar 28, 2023 4:26pm EDT

Ekso Bionics Reports Fourth Quarter and Year End 2022 Results

Mar 20, 2023 8:00am EDT

Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023

Feb 23, 2023 8:00am EST

Ekso Bionics to Showcase Integrated Functional Electrical Stimulation for Indego Therapy at APTA Meeting

Dec 05, 2022 8:37am EST

Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin Corporation

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …25
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Ekso Bionics Holdings, Inc. All Rights Reserved.
Sitemap